New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2013
13:32 EDTDVADaVita partners with Fresenius Medical Care
DaVita, the kidney care division of DaVita HealthCare Partners (DVA) announced an agreement to provide certain pharmacy services to Fresenius Medical Care. FMC, a leading provider of dialysis services and maker of dialysis products, will use DaVita Rx prescription drug services for its Medicare patients in the United States. Congress required that beginning in 2011, some oral medications will be included in the bundled payment model. By 2016 all oral end stage renal disease medications will be included in the bundled payment. FMC's contract with DaVita Rx will help implement that requirement by using DaVita Rx's state-of-the-art pharmacy to fill and ship oral medications to FMC Medicare patients. DaVita Rx service for FMC will begin in late 2013.
News For DVA From The Last 14 Days
Check below for free stories on DVA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 21, 2014
10:02 EDTDVAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:43 EDTDVADaVita downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
July 18, 2014
16:05 EDTDVADaVita says CEO of HealthCare Partners subsidiary to step down
DaVita HealthCare Partners announced that HealthCare Partners, or HCP, president and CEO Dr. Craig Samitt is stepping down from HCP effective August 1. Kent Thiry, co-chairman and CEO of DaVita HealthCare Partners, will take over the role of CEO of HCP, working in tandem with the office of Chief Medical Officer.
July 17, 2014
07:00 EDTDVAFresenius Medical shares should be bought, says Bernstein
Bernstein notes that Fresenius' (FMS) stock has sharply underperformed versus its competitor, DaVita (DVA), since May 2012. But the firm predicts that Fresenius' core U.S. business should outperform that of DaVita going forward. Bernstein adds that it finds Fresenius' business units aside from its U.S. dialysis clinics more attractive than DaVita's businesses other than its U.S. dialysis clinics.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use